DINGDANG HEALTH (09886) spent HK$19,800 on March 31 to repurchase 22,000 shares.
Dingdang Health (09886) announced that on March 31, 2026, they will spend HKD 19,800 to repurchase 22,000 shares.
DINGDANG HEALTH (09886) announced on March 31, 2026 that it has spent HKD 19,800 to repurchase 22,000 shares.
Related Articles
.png)
TYCOON GROUP (03390) released its annual performance, with a net profit attributable to shareholders of HK$15.67 million, representing an increase of 383.64% year-on-year.
China Securities Co., Ltd. (06066) has elected Dong Hongfu as a non-executive director.
VANKE OVERSEAS (01036) released its annual performance results, with a revenue of 597 million Hong Kong dollars. The company will continue to focus on quality investment opportunities.
TYCOON GROUP (03390) released its annual performance, with a net profit attributable to shareholders of HK$15.67 million, representing an increase of 383.64% year-on-year.
China Securities Co., Ltd. (06066) has elected Dong Hongfu as a non-executive director.
VANKE OVERSEAS (01036) released its annual performance results, with a revenue of 597 million Hong Kong dollars. The company will continue to focus on quality investment opportunities.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
